High-Density Lipoprotein Components and Functionality in Cancer: State-of-the-Art

Shiva Ganjali, Biagio Ricciuti, Matteo Pirro, Alexandra E. Butler, Stephen Atkin, Maciej Banach, Amirhossein Sahebkar

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Cancer is the second leading cause of death in western countries, and thus represents a major global public health issue. Whilst it is well-recognized that diet, obesity, and smoking are risk factors for cancer, the role of low levels of high-density lipoprotein cholesterol (HDL-C) in cancer is less well appreciated. Conflicting evidence suggests that serum HDL-C levels may be either positively or negatively associated with cancer incidence and mortality. Such disparate associations are supported in part by the multitude of high-density lipoprotein (HDL) functions that can all have an impact on cancer cell biology. The aim of this review is to provide a comprehensive overview of the crosstalk between HDLs and cancer, focusing on the molecular mechanisms underlying this association.

Original languageEnglish
JournalTrends in Endocrinology and Metabolism
DOIs
Publication statusAccepted/In press - 1 Jan 2018

    Fingerprint

Keywords

  • ABC
  • cancer
  • HDL
  • lipoprotein
  • reverse cholesterol transport
  • SR-BI

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this